| Sep 10 |
United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
|
| Aug 30 |
United Therapeutics Shares Thrive
|
| Aug 30 |
United Therapeutics (UTHR) Up 9.9% Since Last Earnings Report: Can It Continue?
|
| Aug 28 |
Liquidia requests preliminary injunction against FDA for Tyvaso 3-year exclusivity
|
| Aug 28 |
United Therapeutics Corporation's (NASDAQ:UTHR) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
|
| Aug 28 |
United Therapeutics Corporation to Present at Upcoming Investor Conferences
|
| Aug 20 |
Liquidia’s YUTREPIA inhalation powder gains tentative FDA approval
|
| Aug 20 |
Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
|
| Aug 20 |
United Therapeutics: Economics Support Compounding Ability
|
| Aug 19 |
Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38%
|
